Statistics for The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2+ breast cancer cells

Total visits

views
The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2+ breast cancer cells 329

Total visits per month

views
April 2024 0
May 2024 0
June 2024 0
July 2024 0
August 2024 0
September 2024 0
October 2024 0

File Visits

views
herbert-2015-the-telomerase.pdf 350

Top country views

views
United States 221
Germany 19
Ukraine 6
Poland 5
Sweden 5
Canada 4
Luxembourg 3
Russia 3
China 2
United Kingdom 2
Greece 2
Italy 2
Vietnam 2
Australia 1
Brazil 1
Colombia 1
Czechia 1
Iran 1
Malaysia 1
Netherlands 1

Top city views

views
Wilmington 63
Fairfield 37
Ann Arbor 16
Houston 16
Kiez 14
White Plains 12
Cambridge 8
Jacksonville 7
Kiev 6
Kraków 5
Stockholm 5
Washington 5
Lake Mary 4
Diekirch 3
Munich 3
Saint Petersburg 3
Toronto 3
Athens 2
Concord 2
Dong Ket 2
Philadelphia 2
San Francisco 2
Alexandria 1
Beijing 1
Bloomington 1
Bogotá 1
Chicago 1
Grùmolo 1
Gunzenhausen 1
Lake Forest 1
London 1
Milan 1
Mountain View 1
Narara 1
Newark 1
Norwalk 1
Overland Park 1
Saint Louis 1
Scottsdale 1
Seremban 1
Slapanice 1
Stony Brook 1
São Paulo 1
Tehran 1
Utrecht 1